|
Dr. Gold joined Dendreon in 2001 as vice president of business development and was later promoted to chief business officer and then to chief executive officer in January of 2003. Dr. Gold has led the Company�s corporate development acquisition and financing efforts in recent years completing transactions valued at approximately $225 million including the acquisition of Corvas International and raising approximately $240 million in capital. Prior to joining Dendreon he served as vice president of business development for Data Critical Corporation a company engaged in wireless transmission of critical healthcare data now a division of GE Medical. He also served as co-founder president and chief executive officer of Elixis Corporation a medical information systems company. Dr. Gold is a former urologist at the University of Washington and currently serves on the boards of the University of Washington/Fred Hutchinson Cancer Research Center Prostate Cancer Institute and the Washington Biotechnology and Biomedical Association. Dr. Gold received his B.S. from the University of Wisconsin-Madison and his M.D. from Rush Medical College. | 